CJC 1295 (without DAC) CND10 10mg*10vials

CJC 1295 DAC-free CND10 10mg x 10 Vials

Product Overview

CJC 1295 DAC-free CND10 is a high-potency fast-acting physiological growth hormone-releasing hormone analog research peptide in the CND series, representing a saturated version of the CND series, a comprehensive upgrade from the basic CND2 and mid-range CND5. CND10 retains the pure original non-DAC peptide structure, without albumin-binding modification, supporting natural rapid metabolic clearance and clean short-half-life pulsatile growth hormone release characteristic preservation research. Through molecular activity optimization and a high 10mg saturated concentration, CND10 supports maximum intensity pulsatile growth hormone and insulin-like growth factor-1 axis activation and full-amplitude physiological phenotype research, exceeding the efficacy of low- and medium-dose CND series products. Designed for high-dose threshold gradient studies, high-intensity pulsatile anabolic interventions, extreme acute lipid metabolism remodeling research, and high-standard complex peptide synergistic effect validation research, it serves as a core research material for preclinical studies of short-acting physiological endocrine and advanced metabolism in growth hormone peptide drugs.

Core Research Functions

Saturated High-Amplitude Physiological Pulsatile GH Secretion and IGF-1 Strong Transient Increase: Supports saturated high-amplitude physiological pulsatile growth hormone secretion triggering research and insulin-like growth factor-1 strong transient increase studies, supporting body strongest natural intermittent endocrine pulsatile rhythm mimicry research.

Non-DAC Rapid Clearance Mechanism: Supports classic non-DAC rapid clearance mechanism research, excess peptides rapid complete metabolism within approximately 30 minutes short half-life studies, and hormone accumulation, continuous overstimulation, and endocrine desensitization related avoidance research, supporting core advantages distinguishing short-acting GHRH from long-acting DAC-modified peptides research.

High-Intensity Pulsatile Lean Muscle Hyperplasia and Extremely Acute Lipolysis Activation: Supports high-intensity pulsatile lean muscle hyperplasia research, extremely acute lipolysis activation studies, high-load tissue damage repair research, and high-threshold endocrine dose-response mechanism exploration research.

True Physiological Regulatory Logic Maintenance and Significant Experimental Phenotypes Output: Supports true physiological regulatory logic maintenance research, significant experimental phenotypes with maximum data discrimination output studies, meeting stringent data requirements of advanced research, extreme gradient screening, and high-dose peptide combination protocol validation research.

Compared to CND2 and CND5, CND10 supports optimal efficacy in core research dimensions. While maintaining the true physiological regulatory logic, it outputs significant experimental phenotypes with maximum data discrimination, meeting stringent data requirements of advanced research, extreme gradient screening, and high-dose peptide combination protocol validation.

Core Product Advantages

CND10 Comprehensive Flagship Upgrade: The saturated version of the CND series, with optimized molecular target affinity and activity. It retains pure natural non-DAC physiological pulse characteristics while supporting endocrine activation intensity maximization research, exceeding the efficacy limits of CND2 and CND5, suitable for high-threshold advanced research.

Pure High-Fidelity Physiological Pulse Mechanism: Utilizes unmodified original peptide chains, without DAC albumin retention effects. It supports rapid metabolic clearance research, hormone accumulation and pituitary receptor sensitivity long-term maintenance related studies, supporting natural intermittent growth hormone secretion pattern mimicry research in the human body, providing research capabilities that long-acting peptides cannot replicate.

10mg Saturated Concentration Upper Limit: A high-concentration all-around specification, twice as potent as CND5 and five times as potent as CND2. It supports low- and medium-dose version insufficient phenotypic differentiation related problem research, suitable for high-dose extreme gradient experiments and high-intensity acute metabolic intervention modeling.

Clean Low-Interference Endocrine Regulation: Supports GHRH-GH-IGF-1 core pathway targeting with high specificity research, purely physiological pulsatile secretion induction studies, cortisol and prolactin stress hormone interference related studies, ensuring clean experimental variables and reproducible research conclusion studies.

Pharmaceutical-Grade Quality Assurance: Utilizing advanced aseptic vacuum freeze-drying technology to support peptide activity peak stable retention research. Each batch undergoes comprehensive HPLC high-purity testing and is accompanied by a complete Certificate of Analysis (COA). Standard 10-vial aseptic integrated packaging meets the needs of advanced laboratory research, key scientific research projects, drug preclinical development, and bulk wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 10mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).